11 insiders reported 96 Form 4 transactions for Avalo Therapeutics, Inc. (AVTX) over the past 18 months (most recent 2026-08-19). Recent activity: Sullivan Christopher Ryan (Chief Financial Officer) Buy 37,945 shares, Doyle Mittie (Chief Medical Officer) Buy 1,000 shares, Sullivan Christopher Ryan (Chief Financial Officer) Buy 2,876 shares, Doyle Mittie (Chief Medical Officer) Sell 1,000 shares, Sullivan Christopher Ryan (Chief Financial Officer) Sell 37,945 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-19 | Sullivan Christopher Ryan | Chief Financial Officer | Buy | 37,945 | $374,897 |
| 2026-08-19 | Doyle Mittie | Chief Medical Officer | Buy | 1,000 | $12,650 |
| 2026-08-19 | Sullivan Christopher Ryan | Chief Financial Officer | Buy | 2,876 | $28,415 |
| 2026-08-19 | Doyle Mittie | Chief Medical Officer | Sell | 1,000 | $20,000 |
| 2026-08-19 | Sullivan Christopher Ryan | Chief Financial Officer | Sell | 37,945 | $753,333 |
| 2026-08-19 | Sullivan Christopher Ryan | Chief Financial Officer | Sell | 3,749 | $74,762 |
| 2026-08-19 | Sullivan Christopher Ryan | Chief Financial Officer | Buy | 31,031 | $306,586 |
| 2026-08-19 | Sullivan Christopher Ryan | Chief Financial Officer | Sell | 31,031 | $622,324 |
| 2026-08-12 | Doyle Mittie | Chief Medical Officer | Buy | 679 | $5,459 |
| 2026-08-12 | Riley Jennifer | Chief Strategy Officer | Sell | 2,655 | $52,012 |
| 2026-08-12 | Doyle Mittie | Chief Medical Officer | Sell | 679 | $13,580 |
| 2026-07-29 | Doyle Mittie | Chief Medical Officer | Sell | 1,000 | $20,000 |
| 2026-07-29 | Doyle Mittie | Chief Medical Officer | Buy | 1,000 | $12,650 |
| 2026-07-02 | Doyle Mittie | Chief Medical Officer | Buy | 2,875 | $36,369 |
| 2026-07-02 | Doyle Mittie | Chief Medical Officer | Buy | 1,779 | $14,303 |
| 2026-07-02 | Doyle Mittie | Chief Medical Officer | Sell | 4,654 | $93,080 |
| 2026-06-25 | Doyle Mittie | Chief Medical Officer | Buy | 1,450 | $11,658 |
| 2026-06-25 | Doyle Mittie | Chief Medical Officer | Sell | 1,450 | $26,100 |
| 2026-06-12 | VARKI PAUL | Chief Legal Officer | Sell | 1,081 | $14,161 |
| 2026-06-12 | Sullivan Christopher Ryan | Chief Financial Officer | Sell | 138 | $1,808 |
| 2026-06-12 | Doyle Mittie | Chief Medical Officer | Sell | 1,084 | $14,200 |
| 2026-06-12 | Riley Jennifer | Chief Strategy Officer | Sell | 588 | $7,703 |
| 2026-06-01 | Doyle Mittie | Chief Medical Officer | Buy | 679 | $5,459 |
| 2026-06-01 | Doyle Mittie | Chief Medical Officer | Sell | 679 | $10,864 |
| 2026-05-26 | Riley Jennifer | Chief Strategy Officer | Buy | 34,200 | $0 |
Source: SEC Form 4 filings · as of 2026-08-19